• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Pacific Medical Law

A founding member of BILA

Law, Justice And Compassion | Call Today

1-604-685-2361

  • Home
  • Team
  • Injuries
    • Birth Injury
    • Brain Injury
    • Cerebral Palsy
    • Infant & Child Injuries
    • Spinal Cord Injuries
  • Janna Epp Bursary
  • Cases Won
  • Publications
  • Blog
  • Patient’s Corner
  • In The News
  • Contact
  • Home
  • Team
  • Injuries
    • Birth Injury
    • Brain Injury
    • Cerebral Palsy
    • Infant & Child Injuries
    • Spinal Cord Injuries
  • Janna Epp Bursary
  • Cases Won
  • Publications
  • Blog
  • Patient’s Corner
  • In The News
  • Contact
Call
Contact
Blog

Health News

Must Doctors Refer for Services They Oppose?

Monday, July 29, 2019 By Andrea Donaldson

Ontario’s highest court has ruled that doctors there must provide referrals to patients for services they oppose on moral or religious grounds.

Recently the Ontario Court of Appeal upheld a lower court judgment requiring doctors to comply with the “effective referral requirement” of the province’s College of Physicians and Surgeons. An effective referral requires the doctor to make an effort to connect their patient with another willing, available, and accessible health care provider if they oppose the treatment or service the patient seeks. They are not required to make a formal referral by providing a letter and arranging an appointment with another physician, except in an emergency where it is necessary to prevent imminent harm to a patient. Rather, the physician can ask staff to handle the referral. Alternatively, the court suggested that physicians could choose to specialize in a type of medicine where the issue of referrals for treatments they oppose is less frequent.

The intent of the College’s effective referral policy is to ensure that patients are not left to find a willing physician on their own without any assistance from the physician from whom they first sought care. A group of individual physicians and organizations argued that the policy infringes on their freedom of religion and challenged its constitutionality. They believe that the effective referral requirements would make them complicit in performing the procedures that they oppose.

The medical procedures objected to include abortion, contraception, infertility treatment, prescription of erectile dysfunction medication, gender re-assignment surgery, and medical assistance in dying. As noted by the court, these are often the most private, emotional, and challenging issues for patients to raise and discuss, even with a trusted family physician. As well, some of these decisions frequently confront already vulnerable patients:  those with financial, social, educational or emotional challenges; those who are young, old, poor, or addicted to drugs; those with mental health challenges or physical or mental disabilities; those facing economic, linguistic, cultural or geographic barriers; and those who do not have the skills, abilities, or resources to navigate their way through a complicated health care system. Family physicians fulfill the important role as “gatekeepers” and “patient navigators” for health care services. Further, decisions concerning many of these procedures are time-sensitive. A delay in accessing these procedures due to the absence of a referral can prevent access to them altogether.

The court stated that the effective referral policy is a compromise between rights of physicians and interests of patients, but ultimately found that patients should not bear the consequences of physicians’ religious objections. The nature of the physician-patient relationship requires physicians to act at all times in the best interests of their patients and to avoid conflicts between their own interests and their patients’ interests. The court found that the “general information” model proposed by the doctors opposing the policy (in which doctors would provide information or resources, but the patient would assume the responsibility for finding a non-objecting physician) would not meet the needs of most patients seeking personal and urgent medical advice and care, as few procedures can be accessed without a referral from a physician. In smaller, non-urban settings, patients may have additional difficulty in identifying a non-objecting physician given the more limited range of providers.

The court noted that while the effective referral policy of the Ontario College is not a perfect one for all physicians, it is not a perfect one for their patients either: they will lose the personal support of their physicians at a time when they are most vulnerable. The court found, however, that the College’s policy represented the best compromise possible between both sides with the goal of promoting equitable access to health care.

The British Columbia College of Physicians and Surgeons agrees that patient well-being is the single most important factor in ensuring an effective referral consultation process. The BC College, however, does not go as far as Ontario in requiring an effective referral. While physicians may make a personal choice not to provide a treatment or procedure based on their values and beliefs, the BC College only expects them to provide patients with enough information and assistance to allow them to make informed choices for themselves. This includes advising patients that other physicians may be able to see them, or suggesting that the patient visit an alternate health care provider. Where needed, physicians must offer assistance and must not abandon the patient, and must always treat the patient with dignity and respect. The College states that physicians in these situations should not discuss in detail their personal beliefs if not directly relevant and should not pressure patients to disclose or justify their own beliefs. In all cases, physicians must practice within the confines of the legal system and provide compassionate, non-judgmental care. Physicians are not obliged to see all patients, but they are required to treat those in need of emergent or urgent medical care.

*image courtesy of University Health News – universityhealthnews.com

Filed Under: Health News, Legal News

Scientists Develop Method to Convert Brain Signals into Speech

Monday, June 3, 2019 By Andrea Donaldson

Many people – including some of our clients – have lost the ability to speak following accidents, injuries such as strokes, or neurodegenerative disorders. Scientists have recently developed a method that could dramatically impact the way these people are able to communicate.

People who have lost the ability to speak as a result of injury or disease are often forced to use painstaking means of communication using small physical movements, such as head or eye movements. A famous example, physicist Stephen Hawking, used a muscle in his cheek to type keyboard characters which a computer then generated into speech. Now, scientists have developed a way to use brain signals to program a computer to mimic natural speech. As reported recently in Nature, scientists have developed a system that decodes the brain’s vocal intentions and translates them into speech. The hope is that one day, this technology could be used to help people who cannot speak.

Previously, researchers have been able to decode brain signals that indicate the recognition of letters and words (sound representations), but those approaches were not as fluid or fast as natural speech, only producing speech at a rate of about eight words per minute. The new system works by deciphering the brain’s motor commands that guide vocal movements during speech – tongue and lip movements – and generates intelligible sentences that approximate the individual’s natural rhythm of speech. This new system, which represents a leap from decoding single syllables to sentences, is able to produce about 150 words per minute, the natural pace of speech.

In researching this new method, participants were implanted with electrode arrays, which are stamp-sized pads containing hundreds of electrodes placed on the surface of the brain. Each participant recited hundreds of sentences, and the electrodes recorded the firing patterns of neurons in the brain. The researchers associated those patterns with the subtle movements of the participant’s lips, tongue, larynx, and jaw that occur during speech. The team then translated these movements into spoken sentences. Simply mimicking the act of speaking provided the computer with enough information to recreate several of the same sounds.

The researchers then had people listen to the virtual voices to assess the fluency, and found that approximately 70% of the virtual speech produced was intelligible. The study showed that the speech decoder works with mimed or mimicked words, but it is still unclear if it would work with words that people only think, without moving their mouth. The team is planning to move to clinical trials to further test the system.

The team also found that a synthesized voice system could be used and adapted by someone else, suggesting that an off-the-shelf virtual voice system could be possible one day. The field of brain-machine interface technology, as it is known, is rapidly advancing, with teams around the world adding refinements that could be tailored to a specific injury.

 “With continued progress,” wrote Chethan Pandarinath and Yahia H. Ali, biomedical engineers at Emory University and Georgia Institute of Technology, in an accompanying commentary to the study, “we can hope that individuals with speech impairments will regain the ability to freely speak their minds and reconnect with the world around them.”

Filed Under: Health News

Can Science Address the Credibility Conundrum of Chronic Pain?

Monday, May 13, 2019 By Brenda Osmond

Chronic pain is part of many personal injury, motor vehicle, and medical malpractice claims. Since chronic pain is something that can’t be seen or measured, it can be difficult for the courts to understand the severity of the pain, or the impact it can have on a plaintiff’s day-to-day functioning. Do recent advances in neuro-imaging such as functional MRI (fMRI) offer potential solutions to these challenges? In this paper, I will review developments in neuro-imaging and their applicability in negligence claims.


Chronic pain is a feature of many personal injury, motor vehicle, and medical malpractice claims. The characterization of chronic pain for the courts can be complicated by a plaintiff’s pre-existing conditions, their poor memory and sometimes even their inability to describe their current symptoms and the impact they have on their day-to-day functioning.

Advances in neuro-imaging are held out by some as potential solutions to these challenges. In this paper I will review developments in neuro-imaging and consider their usefulness and applicability to negligence claims.

Brain Imaging

One form of imaging that is actively being investigated as an objective measurement of pain is functional magnetic resonance imaging (fMRI). fMRI detects patterns of blood flow in the brain which reflect brain activity, allowing researchers to examine if there are neurological correlates for mental experiences. The goal is to be able to identify a particular pattern of brain activity that aligns with a particular mental state. (1)

A number of potential uses of fMRI brain imaging are being investigated around the globe. In the US, attempts have been made to submit fMRI evidence in court as an advanced form of lie-detection. So far, courts have not admitted this fMRI evidence on the basis that it does not yet meet the standards for admissibility as novel scientific evidence. fMRI is also being researched as a way to distinguish certain types of true and false memories, with a view to addressing the problems inherent in eyewitness testimony. Chronic pain is another area that is receiving attention from researchers who are investigating the ability of fMRI results to provide objective data about pain states. (2)

In 2017 a task force of the International Association for the Study of Pain (IASP) considered the use of brain imaging in the diagnosis of chronic pain and reviewed the ethical and legal implications of its use. The task force, led by neuroscientist Karen D. Davis of Toronto Western Hospital, developed a Consensus Statement (3) addressing medical, legal and ethical issues and described criteria for the evaluation of fMRI measures of pain. The goal was to provide a framework for developing valid protocols for neuroimaging in chronic pain, and a context for the use of neuroimaging in court.

The IASP defines pain as an “unpleasant sensory and emotional experience.” Since pain is, by definition, an emotional experience, the current gold standard for the assessment of pain is self-reporting. (4) Different people exposed to the same pain stimulus can present with a wide range of pain experiences and responses, ranging from the stoic to the histrionic. It is no wonder, then, that there is a great deal of interest in finding more objective methods for evaluating reports of pain. An objective method could prove useful for clinicians in treating pain, for patients trying to better manage their pain, for employers needing to devise accommodation programs for employees, for insurers and of course, the courts.

The Credibility Conundrum

The possibility that a picture – a brain image – could confirm and quantify the nature of a plaintiff is tantalizing. Although courts are often willing to accept expert evidence about the inextricable link between chronic pain and psychological injuries, the plaintiff’s behavior can often cast doubt on the veracity of their claims of pain. For example, in two recent BC cases, the plaintiffs’ demeanor led the courts to comment specifically on their credibility. In Park v Targonski, 2017 BCCA 134 (CanLII) the court found that the plaintiff embellished her pain-related complaints when she was assessed by doctors and when she testified at trial. The trial judge accepted that the plaintiff’s chronic pain and depression were caused by the motor vehicle accident in question, and that her injuries included a profound psychological component, but the judge’s reasons included several adverse findings regarding the plaintiff’s credibility. In Koltai v Wang 2017 BCCA 152 (CanLII) the trial judge had grave reservations about the plaintiff’s credibility due to inconsistencies between his mobility as captured on video surveillance and that demonstrated in independent functional capacity assessments. These inconsistencies brought into question the plaintiff’s reports of pain and the impact it had on his mobility. In these cases, could objective data on the presence and severity of the plaintiff’s pain have assisted the court beyond the assistance already provided by experts who gave evidence?

Brain-imaging techniques have rarely been admitted into evidence at trial. In one case in 2015, a truck driver in Arizona sued his former employer for chronic wrist pain related to a burn caused by molten asphalt. The plaintiff had an fMRI brain scan that demonstrated that lightly touching the affected wrist provoked a signal in sensory regions and other brain areas associated with pain – touching the other wrist did not. The plaintiff’s expert gave evidence that those results could distinguish true pain from imagined pain. The defence called a neurologist who told the court that pain was too subjective to measure in this way and that the signature the fMRI was detecting could have been produced if the plaintiff had expected to feel pain or was unduly concentrating on it. The judge admitted the scan into evidence, and the case settled for $800,000, more than ten times the company’s initial offer. (5,6)

Not surprisingly, a small number of private clinics are now offering fMRI, with some promoting the imaging as being able to document pain and provide objective visual and graphic documentation of pain. Many neuroscientists are concerned that the technology is far from being accurate enough for the courtroom. (7)

Can You Outsmart a Brain Scan?

How accurate is the technology? Is it possible to “trick” an fMRI?

Studies designed to test the robustness of fMRI data for lie-detection have shown that deliberate attempts to alter the fMRI readings (countermeasures) could be successful. By having participants think of specific memories in order to make answers to neutral questions seem more personally relevant, study participants have been able to significantly alter the accuracy of the brain scan results. (8)

Some authors suggest that neuroimaging for pain signals may offer more robust results than neuroimaging for lie-detection. They suggest this in part based on the theory that attempts at countermeasures during pain neuroimaging would involve self-infliction of pain, making it less likely, and more obvious, if a subject was trying to manipulate the results. (9) Despite that view, there are examples in which subjects have been able to manipulate imaging results even when identifying pain was the goal. In 2005 one study had healthy volunteers lie in an fMRI scanner and touch a hot plate while they were shown a video of flames. The video responded to their brain activity and gave them visual feedback. Volunteers were able to control the intensity of the flame by imagining the pain was more or less severe than it actually was, (10) suggesting that fMRI, as it exists at the moment, may not provide the objectivity necessary to make it reliable evidence in court.

Aside from the issue of a subject’s attempts to “out-smart” the fMRI scan, this research shares challenges common to many other forms of research – contrived lab settings might not reflect real-world complexities. (11,12) The emotions that accompany the experience of chronic pain, including the impact on one’s day-to-day activities, and the impact chronic pain can have on loved ones and caregivers may impact on the patient in ways that can’t be objectively measured.

Can Brain Imaging Remove the Subjectivity of Self-Reporting?

The IASP has attempted to distinguish the human experience of pain from its neural processes. In identifying pain as “an unpleasant sensory and emotional experience …” the IASP notes that pain is perceptual and exists only insofar as an individual experiences it. It can only be identified through introspection and honest self-reports. On the other hand, nociception is the “neural process of encoding noxious stimuli,” and can occur without an individual being aware of it. Nociception can even be detected in people under anaesthesia. fMRI measures brain activity and provides information about nociception, and by inference, pain – but this is only a proxy measure of pain. (13)

The experience of pain varies tremendously within and between individuals, and this variability poses a challenge for the use of brain imaging findings as an objective biomarker of pain. (14) In addition, chronic pain often co-occurs with a broad variety of emotional, cognitive and motivational changes, including mental disorders, which further complicates the identification of a specific neuromarker of chronic pain. (15)

Under controlled laboratory settings, fMRI data has shown impressive results. In one study it has been able differentiate between painful and non-painful stimuli with 81% accuracy. In another, fMRI results reported subject’s pain signatures with 93% accuracy. (16) In follow-up tasks, researchers distinguished acute pain from social feelings of rejections, and demonstrated the reduction of pain response upon giving participants analgesic medications. (17) As notable as these results are, the studies all looked at the infliction acute pain in healthy patients, and their applicability to chronic-pain sufferers in the real world is still unknown. (18)

Acute pain is associated with activity in many brain areas that belong to different functional brain systems, rather than with activity in dedicated “pain” centres within the brain.19 Many (if not all) features of brain activity that have been associated with pain are not specific to pain.20 Given that the experience of pain has diverse influences, from nociception to social context, researcher doubt that a single neuromarker will be found to reflect all aspects of acute and chronic pain in all contexts. (21)

Given that pain is, by definition, an emotional experience” perhaps the important question is not “can we remove the subjectivity” but “how do we ensure that the objective data from a brain scan is taken in the context of the plaintiff’s subjective experiences?”

Chronic Pain v. Acute Pain

Although neuroimaging techniques appear to be effective at detecting acute pain caused in the laboratory in healthy volunteers, detecting chronic pain is a different matter. (22) No brain areas or networks have yet been specifically and exclusively linked to chronic pain. In addition, there is a substantial overlap of chronic pain with other processes and comorbidity with mental disorders. This inherent lack of specificity is a fundamental road-block for brain imaging-based diagnostic tests for chronic pain. (23)

Despite these challenges, strides are being made in the realm of imaging and chronic pain. One study looked at the neurological signatures associated with chronic back pain. Painful electrical stimuli were administered to the lower back of chronic pain patients and healthy controls. The fMRI was able to differentiate between pain perceptions in the two subject groups with 92.3% accuracy. (24) Impressive results, but the applicability of those results to the real world remains to be seen.

The Potential Impact of Neuroscience and Neuroimaging Evidence at Trial

An expert’s narrative description of what is seen on any brain imaging can be technical and difficult to follow. Nonetheless, research has suggested that the general public is more likely to accept poor arguments if they are accompanied by neuroscientific evidence. (25) In one study, explanations of psychological phenomena that included even logically irrelevant neuroscience information were more satisfying to lay people than explanations without any neuroscience information. (26)

Demonstrative evidence in the form of an image from an fMRI, can provide a colourful representation comparing a “normal” brain to the plaintiff’s brain. Some authors have suggested that courts should consider limiting expert evidence on the neurobiology of chronic pain to verbal testimony, to ensure that decision-makers are not unduly influenced by being shown visually appealing brain images. (27)

Even if the technological concerns about the utility of fMRI data are overcome, there are additional policy concerns that need to be considered. For example, these scans are likely to remain expensive and may not be available to every plaintiff. There is a possibility that an adverse inference may be drawn against a plaintiff who does not present fMRI results to bolster their complaints of chronic pain. (28)

Conclusion

The use of neuroimaging to find objective evidence of mental states could set up a contest between subjective mental experiences and objective brain states. (29) According to the IASP Consensus Statement, the “most meaningful gauge of a person’s pain is their self-report. Neither the absence of a known cause nor an aberrant response to a stimulus negates the experience of pain. If a patient honestly reports pain, they have pain…” (30)

In its current form, brain imaging is not sufficiently reliable to be used as a “pain detector” to either support or contradict an individual’s self-report of pain. (31) As with many developing scientific fields, future researchers may look back with amusement at what was viewed as a hurdle to acceptance or what was accepted as a panacea. Although data from fMRI cannot be safely generalized to the real world some experts predict that future advances in the neuroimaging technology and analysis will eventually address these problems. (32)

For any brain imaging test to be useful in supporting or refuting a claim of pain it must meet rigorous standards, both of meeting scientific criteria and legal criteria. It must also recognize that each individual is unique, and that abnormal brain activity or structure alone does not prove that an individual is experiencing pain. Imaging results cannot stand alone but need to be assessed in the context not only of the patient’s current medical and behavioural profile, but also of their past experiences. (33)

In Saadati v. Moorhead, [2017] 1 SCR 543, 2017 SCC 28 (CanLII) the court criticized the notion that the task of assessing the plaintiff’s legally recoverable mental injury should be downloaded to a diagnostic classification system. The court held that in adjudicating a claim of mental injury a trier of fact was not concerned with the diagnosis, but with the level of harm that the plaintiff’s symptoms represented. That sentiment may prove relevant to chronic pain and fMRI. If the technology advances enough to allow the results into evidence, the impact of an objective finding of the presence of pain must be taken in the context of the patient’s experience of that pain. The subjectivity of the person’s response to pain will remain a key element in the analysis of the effect of that pain on a plaintiff.


  1. Jennifer A. Chandler, The Impact of Biological Psychiatry on the Law: Evidence, Blame, and Social Solidarity” (2017) 54:3 Alberta Law Review 834.
  2. Chandler ibid at 835.
  3. Karen D. Davis, et al. Brain imaging tests for chronic pain; medical, legal and ethical issues and recommendations. (Oct 2017) 13 Nature Reviews | Neurology 624-638.
  4. Ibid at 624.
  5. Ibid at 625.
  6. Sara Reardon, “The Painful Truth” (2015) 518 Nature 475.
  7. Ibid.
  8. Natalie Salmanowitz, “The case for pain neuroimaging in the courtroom: lessons from deception detection (4 February 2015) Journal of Law and the Biosciences, 144.
  9. Ibid at 146.
  10. Reardon, supra note 6 at 475.
  11. Salmanowitz, supra note 8 at 145.
  12. Davis, supra note 3 at 627.
  13. Ibid at 626.
  14. Ibid.
  15. Ibid at 629.
  16. Salmanowitz, supra note 8 at 141.
  17. Ibid.
  18. Ibid at 142.
  19. Davis, supra note 3 at 627.
  20. Ibid at 628.
  21. Ibid at 629.
  22. Chandler, supra note 1 at 836.
  23. Davis, supra note 3 at 631.
  24. Salmanowitz, supra note 8 at 142.
  25. Reardon, supra note 6 at 476.
  26. Weisberg, D.S., Keil, F.C., Goodstein, S., Rawson, E. & Gray, J.R., The Seductive Allure of Neuroscience Explanations (2008) 20 J. Cogn. Neurosci. 470-477.
  27. Davis, supra note 3 at 634.
  28. Ibid at 635.
  29. Chandler, supra note 1 at 837.
  30. Davis, supra note 3 at 635.
  31. Ibid at 634.
  32. Chandler, supra note 1 at 835.
  33. Davis, supra note 3 at 634.

Filed Under: Health News, Adult Injuries

Can Stem Cell Therapy Help my Child with Cerebral Palsy?

Tuesday, February 12, 2019 By Andrea Donaldson

Parents of children with cerebral palsy are devoted to doing what they can to improve their child’s function and independence.  Often very small improvements in function can result in significant improvements in the quality of a child’s life.

Since we know that some children with cerebral palsy have suffered a brain injury around the time of their birth, it makes sense to try to heal that injury.  When an injury occurs, the brain cells are unable to promote proper growth and development of the brain. Brain cells die or fail to mature, and the white matter tracts that connect different areas of the brain become damaged. In people with CP, the corticospinal tract (CST), which connects regions of the brain that control motor function to the spinal cord, is often damaged. This tract helps to control movement, and without functional CST connections, motor deficits ensue.  The questions is, can stem cell therapy promote new cell growth to replace these damaged brain cells?

What is Stem Cell Therapy?

Stem cell therapy is a regenerative therapy in which stem cells are introduced to replace dead cells and support the remaining cells. Two characteristics make stem cells unique from other cells in the body. First, they have the ability to divide and make copies of themselves over extended periods of time. Second, they can differentiate into more specialized cell types, which means they can transform into specialized cell types of the body such as heart, lung, or brain cells.

Research has shown that stem cells can be induced to become more specialized cell types, and when transplanted into the body, can replace dead cells and support the existing cells. Stem cell transplantation has the potential to replace the damaged and non-functional cells in the brains of CP patients and support the remaining cells.

How Effective is Stem Cell Therapy?

There are a small number of clinical trials around the world assessing how stem cells can be used to treat CP.  So far, there is only one published study of children with CP which found that those who received stem cells in combination with conventional rehabilitation and medication showed greater improvements on cognitive and motor assessments compared to those children who received conventional rehabilitation therapy and medication without receiving stem cells.

Despite the progress seen with pre-clinical (ie. animal studies) and clinical trials in recent years, there are some hurdles that need to be overcome in order for stem cells to become a widely accessible treatment for CP. The first is the problem of the supply of stem cells. Because stem cells are cultured in the laboratory, a lab may only produce enough stem cells to treat one or two patients at a time. As stem cell therapies come closer to the clinic, there is increasing need to develop strategies to manufacture cells on a large scale.

The other problem is that regulatory agencies, such as Health Canada, are having difficulty developing standardized guidelines for the production and use of stem cells. Stem cells are not like conventional drugs; they are living entities and their effects on the human body are not as well-defined as conventional drugs.

Are There any Risks in Trying Stem Cell Therapy?

It must be cautioned that stem cell therapy is still an experimental technique and is not yet ready to be incorporated into the treatment of children with cerebral palsy in Canada. There is a temptation to travel to other countries where it is being offered, with promising testimonials.  Physicians caution against this practice, referred to as “stem cell tourism” noting that there have also been many instances of increasing disability. For example, one of the known problems with stem cell therapy is the risk of the tumour formation. Further, many of the unregulated clinics in North America and overseas use the same types of stem cells to treat a host of different disorders, despite a lack of evidence to support their use.

In conclusion, while stem cell transplantation holds promise and offers hope for improvements in the lives of children living with cerebral palsy, we are only in the early stages of truly understanding its potential.  A realistic expectation is that stem cell therapy may offer small improvements in function that may in turn result in meaningful improvements in the quality of life for children living with cerebral palsy.

If you have a child living with cerebral palsy and you have unanswered questions about what caused their brain injury, and whether or not your child is entitled to compensation for therapy and future care costs, please contact us at 1-604-685-2361.  We would be pleased to discuss your concerns with you and outline the options available for your child.

Filed Under: Cerebral Palsy, Health News

Members of the Pacific Medical Law Team Attend Renowned Obstetrical Conference

Tuesday, January 29, 2019 By Andrea Donaldson

Four members of the Pacific Medical Law Team attended the 35th Annual Obstetrics, Gynecology, Perinatal Medicine, Neonatology and the Law Conference organized by Dr. Aubrey Milunsky and Dr. Jeff Milunsky in January of this year.

The conference was attended by a diverse group of legal and health care specialists. The event featured exceptional presentations by renowned experts in their fields. Presentation topics included:

  • How can maternal injury during childbirth be prevented?
  • When is a home birth safe?
  • Does cooling newborns following a traumatic birth work?
  • What causes stroke in a newborn?
  • What can genetics testing tell us about a child’s disability?
  • What can Magnetic Resonance Imaging (MRI) tell us about when and how a brain injury occurred in a newborn?
  • How long should the second stage (the “pushing” stage) of labour go? and
  • How can medical professionals help promote a culture of patient safety?

The goals of the conference are to teach medical professionals to better understand how to avoid medical negligence and to teach legal professionals about the complex issues encountered in the practice of medicine.

At Pacific Medical Law we are committed to maintaining our knowledge in a range of medical specialties, including obstetrics, gynecology, and neonatology. We believe that understanding the most up-to-date medicine can help us obtain the best results for our clients in medical malpractice lawsuits.

 

 

 

 

Filed Under: Cerebral Palsy, Firm News, Health News

« Previous Page
Next Page »

Primary Sidebar

  • Birth Injury
  • Brain Injury
  • Cerebral Palsy
  • Infant & Child Injuries
  • Spinal Cord Injuries
  • Janna Epp Bursary

Categories

  • Accessibility (24)
  • Adult Injuries (25)
  • Cerebral Palsy (62)
  • Cerebral Palsy Association of BC (26)
  • Community Involvement (31)
  • Firm News (55)
  • Health News (67)
  • Legal News (25)
  • Medical Malpractice (34)
  • People with Disabilities (29)
  • The Verdict – Law Journal (33)
  • Understanding Birth Injuries (1)

Archives

  • September 2025 (1)
  • May 2025 (1)
  • March 2025 (1)
  • November 2024 (1)
  • August 2024 (1)
  • May 2024 (2)
  • November 2023 (1)
  • September 2023 (1)
  • June 2023 (1)
  • March 2023 (1)
  • December 2022 (1)
  • September 2022 (3)
  • January 2022 (2)
  • November 2021 (1)
  • October 2021 (1)
  • August 2021 (1)
  • July 2021 (2)
  • June 2021 (4)
  • April 2021 (2)
  • March 2021 (2)
  • February 2021 (3)
  • December 2020 (1)
  • September 2020 (4)
  • August 2020 (4)
  • June 2020 (1)
  • May 2020 (2)
  • April 2020 (5)
  • March 2020 (1)
  • February 2020 (3)
  • January 2020 (4)
  • December 2019 (3)
  • October 2019 (3)
  • September 2019 (1)
  • August 2019 (3)
  • July 2019 (1)
  • June 2019 (3)
  • May 2019 (2)
  • March 2019 (2)
  • February 2019 (2)
  • January 2019 (5)
  • December 2018 (3)
  • November 2018 (3)
  • October 2018 (4)
  • September 2018 (2)
  • August 2018 (8)
  • July 2018 (8)
  • June 2018 (1)
  • April 2018 (24)
  • March 2018 (1)
  • February 2018 (4)
  • January 2018 (2)
  • July 2017 (1)
  • June 2017 (1)
  • May 2017 (1)
  • April 2017 (1)
  • March 2017 (2)
  • December 2016 (1)
  • September 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • May 2016 (4)
  • April 2016 (1)
  • March 2016 (4)
  • February 2016 (1)
  • January 2016 (1)
  • November 2015 (1)
  • September 2015 (1)
  • August 2015 (1)
  • July 2015 (1)
  • June 2015 (3)
  • March 2015 (1)
  • February 2015 (1)
  • January 2015 (1)
  • November 2014 (1)
  • May 2014 (2)
  • December 2013 (2)
  • November 2013 (1)
  • October 2013 (3)
  • September 2013 (5)
  • August 2013 (2)
  • July 2013 (1)
  • June 2013 (7)

Recent Posts

  • Digital Scribes, Legal Signatures: AI-Generated Records in Medical Malpractice
  • Caught on Camera: The Impact of Photo and Video Evidence in Surgical Negligence Cases
  • Defining the Standard of Care: When Will a Generalist be Held to a Standard Approaching that of a Specialist?
  • The Impact of Contemporaneous Medical Records on Credibility Disputes

How Can We Help You?

Contact Us

Footer

Our Office Location

Pacific Medical Law 1030 6th Avenue West Vancouver, BC V6H 1A3
Toll Free: 1-888-333-2361 Phone: 604-685-2361 Map & Directions

Copyright © 2023 Pacific Medical Law | Website managed by DataRoots